2don MSN
Oliver Chen, TD Cowen senior retail analyst, joins 'Fast Money' to talk what to expect out of Target results tomorrow.
Calumet (NASDAQ:CLMT) -2.8% in Tuesday's trading as TD Cowen downgrades shares to Hold from Buy with a $16 price target, cut ...
Amgen Inc. (NASDAQ:AMGN) 45th Annual TD Cowen Health Care Conference Transcript March 5, 2025 9:10 AM ETCompany ParticipantsJay Bradner - Executive ...
14h
Cryptopolitan on MSNTrump omits crypto in congress speech, signaling it’s not a priority, says TD CowenInvestment bank TD Cowen noted that President Donald Trump did not mention cryptocurrency in his Congress speech.
Moderna, Inc. ( NASDAQ: MRNA) TD Cowen 45th Annual Health Care Conference March 5, 2025 9:10 AM ET All right, well, good morning, everyone. Tyler Van Buren here, Senior Biotech Analyst at TD Cowen.
TD Cowen analyst John Kernan lowered the firm’s price target on On Holding (ONON) to $64 from $66 and keeps a Buy rating on the shares. The ...
Beware a recession that could be triggered by a chain reaction of tariff risk, Wall Street exec says
Economic forecasts have been weakening. While some see slower growth, several commentators see the chance of an outright ...
Calumet Specialty Products Partners (NASDAQ:CLMT – Get Free Report) was downgraded by research analysts at TD Cowen from a ...
Chart Industries (NYSE:GTLS – Get Free Report) had its price objective raised by stock analysts at TD Cowen from $205.00 to ...
2don MSN
We recently compiled a list of the 11 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a ...
In a report released today, Josh Jennings from TD Cowen maintained a Buy rating on Boston Scientific (BSX – Research Report), with a price ...
Investment bank TD Cowen expressed skepticism about the plan, calling it "uncoordinated" and lacking clarity on funding.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results